Terms: = Breast cancer AND NOTCH2, Q04721, 4853, ENSG00000134250, AGS2, hN2
84 results:
1. Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells.
Shuaib M; Chaudhri S; Kumar S
Biomol Concepts; 2024 Jan; 15(1):. PubMed ID: 38525814
[TBL] [Abstract] [Full Text] [Related]
2.
Chen B; Jiang K; Wang H; Miao L; Lin X; Chen Q; Jing L; Lu X
Front Biosci (Landmark Ed); 2023 Sep; 28(9):220. PubMed ID: 37796700
[TBL] [Abstract] [Full Text] [Related]
3. Solid-Basaloid Adenoid Cystic Carcinoma of the breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression.
Shamir ER; Bean GR; Schwartz CJ; Vohra P; Wang A; Allard GM; Wolsky RJ; Garcia JJ; Chen YY; Krings G
Mod Pathol; 2023 Dec; 36(12):100324. PubMed ID: 37660928
[TBL] [Abstract] [Full Text] [Related]
4. Trastuzumab-induced human cardiomyocyte damage through the notch2/JAK2/STAT3 pathway.
Su Z; Liu S; Zou Y; Shan L; Yu M; Xie S; Li X; Jin Y
Clinics (Sao Paulo); 2023; 78():100268. PubMed ID: 37567042
[TBL] [Abstract] [Full Text] [Related]
5. Genomics of
Lipsyc-Sharf M; Jain E; Collins LC; Rosenberg SM; Ruddy KJ; Tamimi RM; Schapira L; Come SE; Peppercorn JM; Borges VF; Warner E; Snow C; Krop IE; Kim D; Weiss J; Zanudo JGT; Partridge AH; Wagle N; Waks AG
JCO Precis Oncol; 2023 Jun; 7():e2300076. PubMed ID: 37364233
[TBL] [Abstract] [Full Text] [Related]
6. Clinical significance of Notch receptors in triple negative breast cancer.
Shah H; Mistry M; Patel N; Vora H
Breast Dis; 2023; 42(1):85-100. PubMed ID: 36970890
[TBL] [Abstract] [Full Text] [Related]
7. Long Non-Coding RNA LINC00052 Targets miR-548p/notch2/Pyk2 to Modulate Tumor Budding and Metastasis of Human breast cancer.
Huang X; Yu J; Lai S; Li Z; Qu F; Fu X; Li Q; Zhong X; Zhang D; Li H
Biochem Genet; 2023 Feb; 61(1):336-353. PubMed ID: 35918619
[TBL] [Abstract] [Full Text] [Related]
8. NOTCH Single Nucleotide Polymorphisms in the Predisposition of breast and Colorectal cancers in Saudi Patients.
Alanazi IO; Shaik JP; Parine NR; Al Naeem A; Azzam NA; Almadi MA; Aljebreen AM; Alharbi O; Alanazi MS; Khan Z
Pathol Oncol Res; 2021; 27():616204. PubMed ID: 34257585
[TBL] [Abstract] [Full Text] [Related]
9. Selenite Inhibits Notch Signaling in Cells and Mice.
Powers M; Liu L; Deemer D; Chen S; Scholl A; Yoshinaga M; Liu Z
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802299
[TBL] [Abstract] [Full Text] [Related]
10. Notch signaling pathway in cumulus cells reflecting zygote and embryo quality in polycystic ovary syndrome.
Masoudi M; Yamini N; Salehi F; Aflatoonian R; Kutenaee MA; Esfandiyari S; Hosseini E; Asadi E; Najarkolaei AH; Mortezaee K; Moini A; Abolhassani F; Salehi E
Arch Gynecol Obstet; 2021 Oct; 304(4):1097-1105. PubMed ID: 33772329
[TBL] [Abstract] [Full Text] [Related]
11. NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer.
Pappas K; Martin TC; Wolfe AL; Nguyen CB; Su T; Jin J; Hibshoosh H; Parsons R
Commun Biol; 2021 Mar; 4(1):312. PubMed ID: 33750924
[TBL] [Abstract] [Full Text] [Related]
12. Association between tumor mutation profile and clinical outcomes among Hispanic Latina women with triple-negative breast cancer.
Philipovskiy A; Dwivedi AK; Gamez R; McCallum R; Mukherjee D; Nahleh Z; Aguilera RJ; Gaur S
PLoS One; 2020; 15(9):e0238262. PubMed ID: 32886682
[TBL] [Abstract] [Full Text] [Related]
13. Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway.
Jiang H; Li X; Wang W; Dong H
BMC Cancer; 2020 Sep; 20(1):838. PubMed ID: 32883233
[TBL] [Abstract] [Full Text] [Related]
14. breast cancer survival and survival gap apportionment in sub-Saharan Africa (ABC-DO): a prospective cohort study.
McCormack V; McKenzie F; Foerster M; Zietsman A; Galukande M; Adisa C; Anele A; Parham G; Pinder LF; Cubasch H; Joffe M; Beaney T; Quaresma M; Togawa K; Abedi-Ardekani B; Anderson BO; Schüz J; Dos-Santos-Silva I
Lancet Glob Health; 2020 Sep; 8(9):e1203-e1212. PubMed ID: 32827482
[TBL] [Abstract] [Full Text] [Related]
15. Cholesterol and Mevalonate: Two Metabolites Involved in breast cancer Progression and Drug Resistance through the ERRα Pathway.
Brindisi M; Fiorillo M; Frattaruolo L; Sotgia F; Lisanti MP; Cappello AR
Cells; 2020 Jul; 9(8):. PubMed ID: 32751976
[TBL] [Abstract] [Full Text] [Related]
16. Genetic alterations and their association with clinicopathologic characteristics in advanced breast carcinomas: focusing on clinically actionable genetic alterations.
Freitag CE; Mei P; Wei L; Parwani AV; Li Z
Hum Pathol; 2020 Aug; 102():94-103. PubMed ID: 32445652
[TBL] [Abstract] [Full Text] [Related]
17. Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells.
Xu Z; Liu C; Zhao Q; Lü J; Ding X; Luo A; He J; Wang G; Li Y; Cai Z; Wang Z; Liu J; Liu S; Li W; Yu Z
Pharmacol Res; 2020 Feb; 152():104628. PubMed ID: 31904506
[TBL] [Abstract] [Full Text] [Related]
18. Precision medicine for human cancers with Notch signaling dysregulation (Review).
Katoh M; Katoh M
Int J Mol Med; 2020 Feb; 45(2):279-297. PubMed ID: 31894255
[TBL] [Abstract] [Full Text] [Related]
19. Requirement of the transcription factor YB-1 for maintaining the stemness of cancer stem cells and reverting differentiated cancer cells into cancer stem cells.
Yang F; Cui P; Lu Y; Zhang X
Stem Cell Res Ther; 2019 Aug; 10(1):233. PubMed ID: 31375149
[TBL] [Abstract] [Full Text] [Related]
20. notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry.
Capulli M; Hristova D; Valbret Z; Carys K; Arjan R; Maurizi A; Masedu F; Cappariello A; Rucci N; Teti A
Br J Cancer; 2019 Jul; 121(2):157-171. PubMed ID: 31239543
[TBL] [Abstract] [Full Text] [Related]
[Next]
